Related Experiment Video
Updated: May 13, 2026
08:43
Intravital Imaging of Axonal Interactions with Microglia and Macrophages in a Mouse Dorsal Column Crush Injury
Published on: November 23, 2014
Inflammatory Bridges: Interconnections Between Alzheimer's Disease and Bone Health
Hengrui Li1,2,3, Wendi Wang2,3, Liping Zhang4
1Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, 271016, China.
Aging and Disease
|March 28, 2025
Summary
This study explores the link between Alzheimer's disease and bone health, highlighting shared inflammatory mechanisms like pyroptosis and oxidative stress. It suggests potential therapeutic targets connecting brain and bone health.
Area of Science:
- Neuroscience
- Immunology
- Gerontology
Background:
- Alzheimer's disease (AD) is a complex neurodegenerative disorder affecting the elderly.
- Neuroinflammation, involving microglia activation and blood-brain barrier (BBB) disruption, is increasingly recognized in AD pathogenesis.
- Bone health issues like osteoporosis and arthritis share common pathways with AD.
Purpose of the Study:
- To establish an inflammatory bridge connecting brain and bone health in the context of aging.
- To summarize shared molecular mechanisms between Alzheimer's disease and bone disorders.
- To review potential therapeutic strategies targeting these shared pathways.
Main Methods:
- Review of existing literature on Alzheimer's disease, bone health, and inflammation.
- Focus on shared mechanisms: NLRP3-induced pyroptosis, advanced glycation end products (AGEs), oxidative stress, macrophage autophagy/lysosomal function, and calcium ion dysregulation.
- Analysis of age-related inflammatory processes.
Main Results:
- Identified age-related NLRP3-induced pyroptosis as a key shared mechanism.
- Highlighted the roles of AGEs, oxidative stress, and altered macrophage function in both conditions.
- Demonstrated calcium ion dysregulation as a common factor linking brain and bone pathology.
Conclusions:
- Shared inflammatory pathways provide a novel perspective on the link between Alzheimer's disease and bone health.
- Targeting these common mechanisms may offer new therapeutic avenues for both conditions.
- Further research into the brain-bone axis is warranted for integrated treatment strategies.
More Related Videos
09:33Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...